American Portfolios Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
BCM
EC
BG
American Portfolios Advisors's TNDM Position: Q3 2022 in Review
American Portfolios Advisors reduced its Tandem Diabetes Care (TNDM) stake by 48% in Q3 2022, selling an estimated $5.98K and leaving 118 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.
American Portfolios Advisors first reported a position in TNDM in Q3 2018 and has held it in 17 quarters since. The position peaked at $587K in Q1 2019. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.
- American Portfolios Advisors held 118 shares of Tandem Diabetes Care worth $5.65K as of Q3 2022.
- American Portfolios Advisors sold 109 Tandem Diabetes Care shares in Q3 2022, an estimated $5.98K.
- Tandem Diabetes Care made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2773 holding.
- American Portfolios Advisors first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 17 quarters since.
- American Portfolios Advisors's Tandem Diabetes Care position peaked at $587K in Q1 2019.
- 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.